Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TherapeuticsMD Q2 EPS $(0.09) Up From $(0.24) YoY, Sales $234.00K Down From $437.00K YoY

Author: Benzinga Newsdesk | August 12, 2024 03:21pm
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.09) per share. This is a 62.5 percent increase over losses of $(0.24) per share from the same period last year. The company reported $234.00 thousand in sales this quarter. This is a 46.45 percent decrease over sales of $437.00 thousand the same period last year.

Posted In: TXMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist